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All organisms contain thioredoxin (TRX), a regulatory thiol:disul-
fide protein that reduces disulfide bonds in target proteins. Unlike
animals and yeast, plants contain numerous TRXs for which no
function has been assigned in vivo. Recent in vitro proteomic
approaches have opened the way to the identification of >100 TRX
putative targets, but of which none of the numerous plant TRXs
can be specifically associated. In contrast, in vivo methodologies,
including classical yeast two-hybrid (Y2H) systems, failed to reveal
the expected high number of TRX targets. Here, we developed a
yeast strain named CY306 designed to identify TRX targets in vivo
by a Y2H approach. CY306 contains a GAL4 reporter system but also
carries deletions of endogenous genes encoding cytosolic TRXs
(TRX1 and TRX2) that presumably compete with TRXs introduced as
bait. We demonstrate here that, in the CY306 strain, yeast TRX1
and TRX2, as well as Arabidopsis TRX introduced as bait, interact
with known TRX targets or putative partners such as yeast perox-
iredoxins AHP1 and TSA1, whereas the same interactions cannot be
detected in classical Y2H strains. Thanks to CY306, we also show
that TRXs interact with the phosphoadenosine-5-phosphosulfate
(PAPS) reductase MET16 through a conserved cysteine. Moreover,
interactions visualized in CY306 are highly specific depending on
the TRX and targets tested. CY306 constitutes a relevant genetic
system to explore the TRX interactome in vivo and with high
specificity, and opens new perspectives in the search for new
TRX-interacting proteins by Y2H library screening in organisms
with multiple TRXs.
affinity chromatography  gene disruption  thioredoxin targets 
two-hybrid system  redox
Thioredoxins (TRXs) are small heat-stable oxidoreductases con-taining two redox-active half-cysteine residues in an active site
with a conserved amino acid sequence CXXC (where X indicates
various amino acids) (1). TRXwas originally identified as hydrogen
donor for the reduction of methionine sulfoxide (MetSO) (2) and
of sulfate (3) in yeast and received its name when it was charac-
terized as a small protein dithiol hydrogen donor toEscherichia coli
ribonucleotide reductase (4). TRX is a hydrogen donor to perox-
iredoxins (5) and is also required for a number of metabolic
enzymes as part of their catalytic cycle. TRX is implicated in many
cellular processes, including protein folding and regulation of
transcription factors (6), protein repair after damage by oxidation,
sulfur metabolism (7, 8), reduction of dehydroascorbate (9), ger-
mination, or reduction of the Calvin cycle and stromal enzymes in
plants (10, 11).
Occurrence of TRXs in all genomes is highly variable and
somewhat complex, depending on the organisms concerned. Most
organisms, such as E. coli, the yeast Saccharomyces cerevisiae, and
mammals (12) contain a limited number of TRX or TRX-like genes
(usually fewer than five). In contrast, plants possess numerous TRX
isoforms (13, 14) or TRX-like proteins (11, 13–15). During the
latest inventories in the Arabidopsis genome, 40 TRX isoforms
have been identified (14). Such diversity raises the problem of the
function and specificity of each TRX. To answer these questions,
much recent work has been devoted to large-scale searches for their
putative targets. Various improved in vitro proteomic approaches
[such as affinity chromatography (16–21), labeled gel electrophore-
sis in which target proteins are revealed after reduction of protein
extract by a TRXNADPH thioredoxin reductase (NTR) system
(22–24), or coimmunoprecipitation (25)] suggested 100 putative
TRX targets, but for which further investigations will be required
for target validation regarding TRX specificity. Other methods
devoted to the large-scale isolation of TRXtarget complexes
established in vivo have also been developed, including affinity
chromatography of TRXtarget complexes established in vivo
during cell culture or the yeastmammalian two-hybrid methods
(26–31). However, such in vivo methods have led to the identifi-
cation of only a few true TRX-interacting proteins. Their low
efficiency to reveal TRX targets is directly correlated with the
presence of functional endogenous TRX proteins in organisms in
which large-scale search of TRX-interacting proteins is performed.
These endogenous TRXs either compete with the foreign TRXs
used as bait or most probably reduce the disulphide bond estab-
lished in vivo between the TRX bait and its target protein (26).
In the presentwork, we have developed a yeast two-hybrid (Y2H)
system to allow high throughput detection of TRXtarget interac-
tions in vivo. The main characteristic of this genetic selection is to
bypass the disulfide bond reduction by endogenous yeast TRX1 and
TRX2 cytosolic proteins, while establishing in vivo interaction
between TRX introduced as bait and its putative targets. For this
purpose, we created a yeast strain, termed CY306, that is depleted
in both TRX1 and TRX2 genes but bears a functional Gal4 Y2H
system.We show that CY306 exhibits the same phenotypes as those
previously described for other trx1 trx2 yeast mutants. Thanks to
strain CY306, we demonstrate in vivo Y2H interactions between
TRXs and known or putative TRX targets that could not be
revealed to date by classical Y2H systems or other in vivo systems.
We specially show here that the yeast TRX2 interacts specifically
with yeast AHP1 and TSA1 peroxiredoxins involved in oxidative
stress response, whereas TRX1 preferentially interacts with PAPS
reductase (MET16), an enzyme involved in sulfate assimilation.
RegardingMET16, the use of CY306 was of great help in revealing
the cysteine residue required for TRX binding. Finally, the high
level of specificity in TRXtarget recognition obtained by the
CY306 Y2H system contrasted with that observed by a His-tag
affinity chromatography (His-TAC) approach with the same TRX
baits. The use of the CY306 strain will be of great help first in
analyzing by Y2H the numerous potential targets already isolated
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in vitro, especially in plants, and second in opening new perspectives
for the systematic in vivo search for new TRX-interacting proteins
in all organisms.
Materials and Methods
Strains and Media. The yeast strain EMY63 (32) was used for both
phenotypic comparisons and production of recombinant TRXs.
The Y2H strains YRG2 (Stratagene) and YM954 (33) were used
for deletion ofTRX1 andTRX2, respectively. Construction of strain
CY306 was achieved by the long flanking homology method (34)
and is described in Supporting Materials and Methods, which is
published as supporting information on the PNAS web site. Chem-
icals [H2O2, tert-butyl hydroperoxide (t-BOOH), diamide,Met, and
MetSO) were purchased from Sigma. All media are detailed in
Supporting Materials and Methods.
Molecular Cloning. Yeast and Arabidopsis ORFs, primers, and
MluI.NaeI.BglII (MB) adaptor used in this study are given in Table
2, which is published as supporting information on the PNAS web
site. PCR products were obtained by using the long expand
template enzyme (Roche Applied Science). Mutation of cysteine
residues was obtained by using the Site-Directed Mutagenesis kit
(Stratagene). All DNA fragments were systematically checked by
sequencing.
TRX His-Tagging and Purification of TRXTarget Complexes. TRX
baits were cloned into a modified version of the pFL61 shuttle
vector (ref. 35 and Supporting Materials and Methods) and were
separately introduced in EMY63 strain for production of recom-
binant His-tagged TRX baits. Cultures, protein extractions, and
complex purifications were performed as described (26) by using 1
ml ofHisBindNi2 resin (Novagen) per liter of cell cultures (OD600
ranging between 1.4 and 2). Protein complexes were treated
immediately or frozen at 80°C.
Protein Analysis. Extraction of total proteins for immunoblot anal-
yses are described in SupportingMaterials andMethods. All proteins
were quantified by using a protein assay kit (Bio-Rad). Proteins for
mass spectrometry were concentrated by using frozen acetone and,
once lyophilized, were solubilized in 500 l of solubilization buffer
[9 M urea4% CHAPS (3-[(3-cholamidopropyl)dimethylammo-
nio]-1-propanesulfonate)0.5%Triton X-1000.5 immobilized pH-
gradient (IPG) buffer (Amersham Pharmacia)3 mM tributyl
phosphin]. Proteins (300 g) were first separated along linear IPG
strips (pH 3–10, 18 cm long) by using an IPGphor apparatus
(Amersham Pharmacia Biosciences) and further treated as de-
scribed (36). Second dimensions were performed in 13%polyacryl-
amideSDS gels. Proteins were stained by colloidal Coomassie and
digested by trypsin, and individual spots were analyzed byMALDI-
TOF (BIFLEX III, Bruker, Billerica, MA) at the Montpellier LR
Genopole (France).
Two-Hybrid Experiments. All experiments were performed in the
yeast reporter strains YRG2 (Stratagene) and CY306 (this study).
cDNAs encoding AtTRXh2ser62, AtTRXh3ser42, the yeast
TRX1ser33, and TRX2ser34 are available in our laboratory and were
cloned at EcoRI-BamHI sites of pGBKT7 (Clontech). Target
cDNAs [AHP1, TSA1, methionine sulfoxide reductase (MSRA),
andMET16] were obtained by PCRamplification on yeast genomic
DNA by using restriction site-containing primers (Table 2), and
cloned into pGADT7 (CLONTECH) at corresponding sites.
AtTDX[270–380] and SSB2 constructs are from ref. 37. Double
transformants in YRG2 and in CY306 strains were selected as cells
growing in the absence of leucine and tryptophan, and in the
presence of Met and geneticin for CY306 strain. Cells bearing
interacting proteins were selected on media lacking leucine, tryp-
tophan, and histidine, but containing Met and 20 mM 3-aminotria-
zole (3AT), and tested for -galactosidase activity as described
(Stratagene).
Results
Development and Phenotypic Analysis of CY306 trx1 trx2 Two-
Hybrid Yeast Strain. The aim of our study was to obtain a new yeast
two-hybrid strain allowing the search for specific thioredoxin tar-
gets in vivo, by getting rid of competition between the TRX
introduced as bait and endogenous TRXs. For this purpose, our
strategy consisted in replacing both endogenous TRX1 (ORF
YLR043C) and TRX2 (ORF YGR209C) genes by a KanMX4
cassette in a Y2H strain, leading to a trx1 trx2 mutant strain
named CY306. The feasibility of such a genetic system was based
on the good knowledge of yeast trx1 trx2 mutants [such as the
EMY63 trx1 trx2 strain (32)] that remain viable despite several
severe phenotypes (32).
We next performed phenotypic analyses on CY306 cells to
confirm that this strain behaves like other yeast trx1 trx2mutants.
Because trx1 trx2 mutants are unable to grow on media con-
taining sulfate as the sole source of metabolic sulfur (32), organic
sulfur auxotrophywas the second criterion after geneticin resistance
that allowed us to select the CY306 trx1 trx2 cell lines during
tetrad analysis. CY306, like EMY63 trx1 trx2 mutant, is unable
to grow on a medium lacking Met as sole source of organic sulfur
(Fig. 1A). Similarly, CY306 cells are unable to grow on B medium
containingMetSOas source of sulfur (Fig. 1A), as previously shown
for EMY63 strain (38). Because strains deleted for both TRX1 and
Fig. 1. CY306 yeast cells are true trx1 trx2 mutants regarding Met
auxotrophy and sensitivity to oxidative stress. (A) CY306 cells are unable to
grow on solid yeast extract nitrogen base (YNB) medium without Met and
cannot reduce MetSO. (B) CY306 cells are also sensitive to oxidant molecules
such as H2O2 and t-BOOH. (C) Effect of diamide and DTT on CY306 growth. In
B, C, and D, control plates contain 1 mM Met. Cultures of wild-type (YRG2,
YM954), single mutant (yrg2 trx1; ym954 trx2), and double mutant (EMY63
trx1 trx2; CY306 trx1 trx2) cells were grown into stationary phase and
adjusted to an OD600 of 0.5, 5  102, and 5  103 before spotting onto
appropriate plates. Plates were incubated at 30°C for 3 days before scoring
growth. Results shown here are the means of three independent experiments.
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TRX2 are also hypersensitive to oxidant molecules such as H2O2
(32) and t-BOOH (39), we checked that CY306, like EMY63
mutant, is unable to grow on plates containingH2O2 (Fig. 1B). Both
strains were also unable to grow on plates containing 0.8 mM
t-BOOH (Fig. 1B). Interestingly, the ym954 trx2 mutant was also
unable to grow, suggesting that TRX1 cannot compensate the
function of TRX2 in the case of reduction of alkyl hydroperoxides
by TRXs. Finally, the CY306 mutant showed resistance to diamide
and sensitivity toward DTT (Fig. 1C), similarly to trx2 (32) and
trx1 trx2 (40) mutants. Altogether, these results indicate that the
CY306 strain is true trx1 trx2 mutant regarding phenotypes.
CY306 trx1 trx2 Yeast Strain Is a Y2H Tool That Reveals Thioredoxin
Targets in Vivo. To evaluate the efficiency of the Y2HCY306 strain
to reveal interaction involving thioredoxins, binary interactions
between TRXs and putative targets were assayed in both the
mutant CY306 and the wild-type YRG2 strains. All TRXs used as
bait carried amutation of the second cysteine of the TRXactive site
into a serine (TRX1ser33 and TRX2ser34), in accordance with the
ability ofmutated TRXs to establish stablemixed disulfide complex
in vivo (26). Four different targets were chosen, either because they
had already been described as TRX targets by other means, or
because of strong presumption that they are TRX targets.
The first protein tested was the thioredoxin-dependent peroxi-
dase AHP1, a yeast protein involved in alkyl hydroperoxide detox-
ification (39, 41). Biochemical and genetic evidence indicates that
AHP1 is a TRX target (26) and is consistent with sensitivity of trx1
trx2 yeast mutants to H2O2 and t-BOOH. However, a previous
study using classical Y2H systems failed to reveal a TRXAHP1
interaction (26). Fig. 2A shows that, in the mutant strain CY306, a
faint interaction could be detected between TRX1ser33 and AHP1,
and between TRX2ser34 and AHP1 to a much greater extent. We
also tested the interaction between both TRXs and TSA1, a
thiol-specific antioxidant also involved in hydroperoxide detoxifi-
cation and that requires the TRXNADPH thioredoxin reductase
(NTR) reductase system (5).A strong interactionwas obtainedwith
TRX2ser34 only in the CY306 strain (Fig. 2B), whereas no interac-
tion was found with TRX1ser33. None of the two TRXs interacted
with both targets in the YRG2 strain.
Another putative TRX-interacting protein that was assayed is the
yeast MSRA. MSRA is another antioxidant enzyme that exerts its
protection against oxidative stress by maintaining a low level of
oxidizedMet, either in protein-bound or free amino acid form (42).
In vivo and in vitro analyses of yeast (38) and E. coli (43, 44) TRX
mutants indirectly suggested that TRX is the reductase that reac-
tivates methionine sulfoxide reductase (38, 43, 44), which is con-
sistent with the inability of trx1 trx2 yeast mutants to grow on
plates containing MetSO as the sole Met source (ref. 38 and this
work). As shown in Fig. 2C, cells bearing either MSRATRX1ser33
or MSRATRX2ser34 were able to grow on selective medium only
in the strain CY306, thus confirming that both TRXs directly
interact with MSRA in vivo.
All trx1 trx2 yeast mutants described in the literature exhibit
aMet auxotrophy, due to the inability to assimilate inorganic sulfur
(32, 40). In yeast, TRX is required in sulfur assimilation (7, 8) and
is supposed to ensure the reduction of a conserved cysteine in the
PAPS reductase (MET16), a key enzyme required for Met biosyn-
thesis (45). We actually found a strong interaction betweenMET16
and TRX1ser33 in CY306 strain (Fig. 2D), but a weaker but
significant interaction with TRX2ser34 could also be demonstrated
in this strain. In both cases, such interactions could not be observed
in the wild-type strain YRG2.
All interactions visualized using His3 reporter gene under Gal4
control were confirmed by using LacZ reporter gene, for both the
presence and intensity of interaction (data not shown). No inter-
action (using both reporter genes) was observed when nonmutated
forms of TRX were used as bait (data non shown).
CY306 trx1 trx2 Yeast Strain Reveals Specific and Low-Abundant
TRX Targets. To compare the efficiency of the CY306 strain and the
TRX-specific Y2H system with other in vivo approaches, we
performed a series of purifications of TRX-target complexes es-
tablished in vivo after production of His-Tagged mutated TRXs in
the yeastmutant EMY63 trx1 trx2. Experiments were performed
by using yeast TRX1ser33 and TRX2ser34 as bait, but alsoArabidopsis
AtTRXh2ser62 and AtTRXh3ser42.
Among the targets identified by MALDI-TOF (Fig. 3), we
confirmedAHP1,TSA1, andMET16 as putative targets. Except for
the case of AtTRXh3ser42, which did not allow TSA1 and MET16
purification, these targets were always isolated (reproductive iso-
lation), independent of the bait used (Table 1). This apparent lack
of specificity contrasted with that observed with the CY306 Y2H
system (Table 1 and Fig. 2). Of particular interest was the nonspe-
cific purification of TSA1 using all baits in the His-TAC method,
although it only interacted with the yeast TRX2ser34 in CY306 (Fig.
2B). In this case, the Y2H result was more consistent with the
putative function of the yeast TRX2 in response to oxidative stress
produced by alkyl hydroperoxides, as shown by phenotypic analyzes
of trx1 trx2 yeast mutants (Fig. 1B and ref. 41). This difference
of specificity between the two targeting systems was also shown
when plant TRXs were used as bait. AtTRXh2ser62 always captured
AHP1, TSA1, and MET16 by the His-TAC method (Fig. 3),
although it interacted with MET16 only by the CY306 Y2H
approach (Table 1). Only the result obtained by using CY306 is
consistent with the ability of AtTRXh2 to complement EMY63
trx1 trx2 mutant for Met auxotrophy by its ability to reduce the
Fig. 2. CY306, but not the classical YRG2 strain, efficiently reports Y2H
interactions involving thioredoxins. The following interactions are observed
only in CY36 cells. (A) TRX1ser33 and TRX2ser34 differentially interact with alkyl
hydroperoxide protein AHP1. (B) TRX2ser34, but not TRX1ser33, interacts with
thiol-specific antioxidant TSA1. (C) MetSO reductase MSRA equally interacts
with TRX1ser33 and TRX2ser34. (D) TRX1ser33, and TRX2ser34 to a lesser extent,
interacts with the PAPS enzyme MET16. In all pictures, control plates (Left)
contain histidine and test plates (Right) contain 20 mM 3-aminotriazole (3-AT)
without histidine. Results shown here are the means of three independent
experiments.
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MET16PAPS enzyme, whereas it is unable to complements
EMY63 for sensitivity to oxidative stress (38).
In the His-TAC approach, we also found that AHP1, TSA1, and
MET16 were always similarly isolated (2D-spot density). On the
opposite, the CY306 strain not only allowed the detection of
TRXtarget interactions in a specific manner, but also revealed
different levels of interaction depending on the partners analyzed
(Table 1).
Finally, except for the mid-abundance MET16 protein, all of the
targets identified by the His-TAC method were high-abundance
proteins (Fig. 3), although we did not identify low-abundance
proteins including the MSRA protein among the 2D-spots. In
contrast, a Y2H interaction could be detected in CY306 between
MSRA and TRXs (Fig. 2C), even when AtTRXh2ser62 and
AtTRXh3ser42 were used as bait (Table 1), which is consistent with
the ability of both proteins to complement the EMY63 trx1 trx2
mutant for reduction of MetSO phenotype (38).
Altogether, these results suggest that, even if theHis-TAC is very
helpful in the isolation of TRX targets, the CY306 Y2H system is
far more sensitive for TRXs target recognition. The CY306 Y2H
system provides information that is consistent with functional
complementation data (38) and the specificity and sensitivity values
that are lacking in the His-TAC system developed here.
CY306 trx1 trx2 Yeast Strain as a Tool to Reveal Essential Cysteines
in TRX Targets.Wefinally investigated the ability of theCY306 strain
to reveal critical residues such as cysteines involved in TRX
interaction with its target. We took as an example the MET16
enzyme that contains two cysteine residues: C112, which does not
possess any catalytic activity (46), and C245 in the consensus
sequence KxECG(LI)H, which is required for MET16 activity
(47). Before this work, the identity of the cysteine residue targeted
by TRX in MET16 was unknown. Two mutated MET16C112S and
MET16C245S were then constructed in pGADT7 and further as-
sayed for interaction with both TRX1ser33 and TRX2ser34. As shown
in Fig. 4, the C112S mutation in the MET16 protein did not affect
its interaction with TRX1ser33 and TRX2ser34 because CY306
growth remained similar to that observed for the wild-type protein.
In contrast, the C245S mutation in MET16 drastically abolished its
binding to both TRXs as revealed by the absence of CY306 growth.
This result first confirmed that C245 is the essential cysteine for
MET16 interaction with TRXs (47). Second, this experiment
demonstrated that the CY306 strain is a functional and reliable tool
to discriminate cysteines targeted by TRXs in vivo.
Discussion
Proteins rarely work by themselves and almost all require other
molecules to execute their functions. TRXs are among such pro-
Fig. 3. Bidimensional electrophoresis of TRXtargets complexes established
in vivo in EMY63 trx1 trx2 cell culture. The different TRXs used as baits are
indicated under the corresponding panels. Numbers refer to identified pro-
teinsORF as follow: 1, alcohol dehydrogenaseYOL086C; 2, glyceraldehyde-
3-phosphate dehydrogenase, isozyme 3YGR192C; 3, glyceraldehyde-3-
phosphate dehydrogenase, isozyme 1YJL052W; 4, thioredoxin reductase
YDR353W; 5, MET16YPR167C; 6 and 12–14, eukaryotic initiation factor 4E
YOL139C; 7, TSA1YML028W; 8–11 and 15, AHP1YLR109W; and 16, D-lactate
dehydrogenaseYEL071W. The pH gradient is indicated above the panels. Size
of markers is indicated in kDa on the left of each panel. Control experiments
using nonmutated TRX exhibited only spots corresponding to the baits used
(data not shown). Results shown here are the means of four independent
experiments for each TRX bait.
Table 1. Comparative analysis between His-TAC and Y2H methods to efficiently reveal specific
TRXtarget complexes in trx1trx2 yeast mutants
Targets
Affinity chromatography* Yeast two-hybrid†
TRX1 TRX2 Ath2 Ath3 TRX1 TRX2 Ath2 Ath3
AHP1        
TSA1    NI    NT
MET16    NI    
MSRA NI NI NI NI    
All TRX baits are mutated and carry a CXXS active site. NT, not tested; Ath2, AtTrxh2; Ath3, AtTrxh3.
*Plus signs (,,), spot density as observed on 2D gels. NI, the corresponding target was not identified
among the 2D spots analyzed.
†Plus signs (,,), the level of two-hybrid interactions;, no interaction occurred between partners tested;
, a faint but reproducible interaction.
Fig. 4. CY306 strain allows detection of the essential cysteine residue in the
PAPS reductase that is required for TRX interaction. Both the TRX1ser33 or
TRX2ser34 baits were tested for two-hybrid interaction with the two variants
MET16ser112 and MET16ser245 of the MET16 enzyme. Cells were grown and
spotted as described in Fig. 1. Results shown here are the means of three
independent experiments.
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teins that were historically shown to be involved in substrate
reduction and regulation of enzymes in physiological conditions. In
the last few years, extended efforts have been devoted to large-scale
searches for potential TRX targets in various organisms. Thanks to
in vitro approaches (affinity chromatography and proteomics),
several nonexhaustive lists of putative TRX targets have been
established, deciphering new pathways and metabolic functions
involving TRXs (11). Because of a real need to go further in the
analysis of TRXtarget complex specificity, we describe here a tool
consisting of a yeast strain devoted to the study of binary protein
protein interactions and Y2H screenings in vivo, specifically de-
signed for the identification and analysis of TRX targets. We
propose that this tool will be of great help, first to assign specific
targets to specific TRXs, and second to isolate new andor low-
abundant candidates for reduction by TRXs in vivo.
A Two-Hybrid System for Thioredoxins. Numerous two-hybrid sys-
tems have been described, most of them using bacterial or yeast
cells. The Y2H system was selected in our strategy for several
reasons. Yeast combines an ease of manipulation comparable with
that of bacteria with the characteristics of eukaryotic cells, such as
posttranslational modifications. The Y2H system is adaptable to
most kinds of baits and targets from any organelle or organism, and
allows not only the study of binary interaction between two
proteins, but also the search for new partners in DNA libraries.
Interactions occur in vivo, which distinguishes this approach from
other protein-targeting methods, and can be performed between
twoproteins fromdifferent organisms.Unfortunately, whenwe first
used commercial Y2H systems to search for TRX targets using
DNA libraries, using yeast or plant TRXs as bait, very few targets
were isolated, in contrast to the numerous putative targets isolated
by using in vitro proteomics (19, 20, 48). Even Y2H binary inter-
actions involving TRX targets isolated by another in vivo method
failed in classical Y2H yeast strains (26). The poor efficiency of
classical Y2H systems to reveal TRX targets has been observed in
previous library screenings (28–30, 49), and only a few TRX
partners have been isolated up to now (27–31). Some TRX-
interacting partners, such asASK1 (50), the SLocus receptor kinase
SRK (51), and theCf-9 protein (52) were also revealed, but in which
TRXswere captured as the targets of these proteins. These data are
consistent with the very few TRX-interacting proteins found by
using large-scale two-hybrid arrays (53, 54). Such screenings have
generated a tremendous amount of protein data and identified
thousands of interactions, among which none or very few involving
a TRX were described (55–57). Interestingly, other in vivo ap-
proaches such as the tandem-affinity purification (TAP) also failed
to reveals TRX-containing complexes (58, 59). All these high-
throughput methods are usually performed in vivo by using wild-
type strains and nonmutated baits, reinforcing the presumption that
the search of TRX targets requires adapted strategies.
The low efficiency of in vivomethods to isolate a high number of
TRX targets could reside in the presence of functional endogenous
TRX1 and TRX2 proteins in strains routinely used for such
strategies. Based on our previous observations using the wild-type
EMY60 yeast strain in a His-TAC in vivo approach (26), we
suspected that endogenous TRXs either compete with the foreign
TRX introduced as bait, andor most probably reduce the newly
established disulphide bond between the TRX bait and its target
protein. Because of our successful experience in isolating the first
TRX target in vivo from an organism depleted in endogenous
TRXs (26) and because the same approach was also successful in
a trxA bacteria (19), we decided to create a yeast strain depleted
in TRX1 and TRX2 genes, devoted to the specific Y2H search and
analysis of TRX targets. The results we present here confirm that
deletion of both TRX1 and TRX2 genes in a Y2H strain leads to an
efficient genetic system that allows visualization of Y2H interac-
tions with foreign TRXs that could not be seen up to now in routine
strains. The nature of Y2H interactions correlates with trx1D trx2D
yeast mutant complementation and phenotypes (38–40). This
finding supports endogenous TRXs competition with TRX bait to
capture protein targets in organisms where they are present, but not
an unlikely differential nuclear import of complexes for Gal4
activation depending on target identity.
Looking for Specificity in Target Recognition by Thioredoxins. To
date, affinity chromatography, combined with proteomics, has
probably been the most powerful tool to reveal a large number of
TRX targets. Extended lists of putative TRX targets have been
obtained from organelles and organisms (11) that have increased
our knowledge about their putative functions, mostly by revealing
pathways involving such dithiol proteins. Nevertheless, some limits
inherent to both methodologies have been brought to light. Con-
cerning affinity chromatography, one may question the unspecific
binding on affinity column of proteins unrelated to TRX function,
the absence of clear results concerning specificity of the targets
regarding cellular compartments, and the variety of proteins cap-
tured by the different dithiol isoforms (21). In ourHis-TAC system,
we also observed low specificity in the targets isolated, probably due
to the use of a multicopy shuttle vector for production of recom-
binant TRX bait in vivo. On the other hand, using CY306 strain, we
found that yeast TRX1 interacts preferentially with the yeast PAPS
enzyme, although TRX2 preferentially interacts with peroxidases
involved in detoxification toward oxidant molecules. Interestingly,
both TRX1 and TRX2 interact with the TRX-dependent AHP1,
whereas only TRX2 interacts with the thiol peroxidase TSA1. The
CY306 Y2H system demonstrates that a specificity in TRXtarget
recognition can be revealed and opens perspectives in deciphering
the true functions of the numerous TRX isoforms. Many putative
targets have already been isolated, even with low specificity, and
could be now tested for Y2H interaction with the different TRX
isoforms originated from the same organism.
CY306 Strain Is a New Tool for the Identification of Residues Required
for TRXTarget Interactions. Interestingly, all interactions shown in
this study were obtained with TRX baits carrying only a Cys-to-Ser
mutation on the second cysteine of the CXXC active site, confirm-
ing the requirement of such mutation to establish stable interme-
diate complexes between the TRX and targets tested here. Nev-
ertheless, several putative targets already isolated by in vitromeans
do not contain any conserved cysteines (18, 60). Other targets
contain cysteines that are not conserved in other organisms (18).
These observations raise the question as to how TRX binds to such
targets.We have shown that CY306 is able to reveal the C245 as the
amino acid targeted by TRX in MET16 protein. The same analysis
could now be performed with other putative targets for which a
questionmark still remains about being trueTRXpartners, by using
both wild-type and mutated TRXs as bait to answer whether
cysteines of both partners are required for interaction.
Searching for Low-Abundant andor New TRX-Interacting Proteins.
One of the realities of large-scale in vitro proteomics is the low
efficiency to reveal low-abundance protein targets. In our His-
TAC approach, almost all of the putative targets isolated by the
His-TAC approach were highly abundant proteins. Despite
several purification experiments, we always failed to isolate
low-copy targets, such as the MSRA protein, probably because
the more abundant targets such as AHP1 quench the foreign
TRX bait. On the other hand, Y2H systems are usually efficient
to detect low-copy-number proteins, such as transcription fac-
tors, because interactions are required for cell life. By using the
CY306 Y2H strain, we obtained an interaction between MSRA
and both TRX1ser33 and TRX2ser34, as well as with AtTRXh2ser62
and AtTRXh3ser42, suggesting that CY306 is better adapted to
reveal low-abundant partners. This result was confirmed by the
isolation of a low-abundant transcription factor of the TFIID
complex from a yeast cDNA library screening using the Y2H
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method (F.V., unpublished results). Our CY306 Y2H system
may contribute to the cloning and characterization of relevant
new TRX targets that have remained unknown up to now
because of their low abundance.
Finally, CY306 remains a relevant genetic system because it
allows the specific search for TRX targets in vivo from any
organism. Except in bacteria (19) and in yeast (32), there is no
organism, especially in plants, depleted in TRX genes that could
allow the search for TRX targets in optimized conditions. Numer-
ous knock-out mutants in TRX genes are available as transposon
and T-DNA [portion of the Ti (tumor-inducing) plasmid that is
transferred to plant cells] lines of Arabidopsis collections, but all
those studied have so far exhibited symptomless phenotypes (C.
Laloi and Y.M., unpublished results). In such lines, gene redun-
dancy andor compensation events by other redoxins most prob-
ably occur (14), preventing the use of strategies such as in planta
TRX-partner tandem-affinity purification (TAP) targeting. Be-
cause the CY306 Y2H system is free of competing endogenous
TRXs, and because it is adapted to all organisms, it opens per-
spectives for library screenings in relation with metabolism, devel-
opment, or tissue specificity.
Concluding Remarks. Deciphering the entire TRX interactome is
now required for our understanding of their functions and inter-
pretation of sequenced genomes. Plants are probably the most
complex organisms regarding TRX gene families, with 40 TRX-
related proteins (e.g., for Arabidopsis). Up to now, we have been
unable to assign a specific TRX to a specific protein among the
numerous putative targets revealed by proteomics. With the avail-
ability of CY306, we hope to overcome this problem. The next step
involves starting aY2H for all of theArabidopsisTRXs and putative
partners already isolated by different means from this plant.
Combined with proteomics, the CY306 tool should be of great help
in exploring the composition of TRX-containing complexes and in
proceeding to TRX biological functions in plants as well as in other
organisms.
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